Foundayo (orforglipron): an explanation of the slimming pill with no specific dosage instructions

Short answer: Foundayo orforglipron is the first small-molecule GLP-1 weight-loss pill. Unlike other oral GLP-1 medicines, you can take it at any time, with or without food and water. It is not yet available in the Netherlands.

Foundayo is the brand name for orforglipron, and this weight-loss pill differs from all previous oral GLP-1 medicines in one key respect. Whereas a tablet such as oral semaglutide must be taken on an empty stomach, Foundayo can be taken at any time of day, without any restrictions on food or water. This is because orforglipron is not a peptide but a small molecule – a difference we explain below. In this article, you can read exactly what Foundayo is, how it works, how effective it is, what side effects it has and when it is expected to become available in the Netherlands.

What is Foundayo?

Foundayo is the brand name for orforglipron, the first weight-loss medicine in tablet form that uses a small molecule rather than a peptide. The medicine was developed by Eli Lilly and was approved by the US FDA on 1 April 2026. This makes it the world’s first non-peptide small-molecule GLP-1 receptor agonist on the market.

The distinction between a peptide and a small molecule is more than just a technical detail. Peptide medicines such as semaglutide are broken down in the stomach, which means strict dosing guidelines are required to ensure sufficient active ingredient reaches the body. Orforglipron is chemically structured in such a way that it remains stable in the gastrointestinal tract, and therefore these guidelines are largely no longer necessary.

How does Foundayo work?

Foundayo works by activating the GLP-1 receptor, just like the well-known injectable treatments. This activation slows gastric emptying, suppresses appetite and prolongs the feeling of fullness, so you eat less without feeling constantly hungry. Anyone who wants to know more about how the GLP-1 mechanism works will find a more detailed explanation there.

The difference from other GLP-1 medicines lies not in the mechanism of action but in the chemical structure. A small molecule is more stable in the gastrointestinal tract than a peptide, and it is precisely this stability that makes a once-daily tablet possible without the need to take it on an empty stomach. Research into the mechanism of action shows that orforglipron activates the receptor via a non-peptide pathway, which explains its stability in the body.

How effective is Foundayo?

Foundayo delivers clinically relevant weight loss comparable to that of injectable GLP-1 agents. A phase 3 trial in patients with obesity shows that, at the highest dose, orforglipron led to weight loss of approximately nine kilos, with a safety profile in line with the existing GLP-1 class. In people with early-stage type 2 diabetes, orforglipron reduced HbA1c by approximately 2.2 per cent, compared with approximately 1.4 per cent for Rybelsus.

Important to remember: that HbA1c result comes from diabetes research, as Rybelsus, the oral semaglutide tablet, is authorised for type 2 diabetes, although, like Ozempic, it is also used off-label for weight loss. The ultimate effect depends heavily on consistent use combined with lifestyle and dietary changes. There are no guarantees, and the figures are averages from studies. In a comparison with oral semaglutide for type 2 diabetes , orforglipron performed at least as well in terms of blood sugar control.

What makes Foundayo different from the Wegovy tablet?

The main difference is the flexibility of when to take it: you can take Foundayo at any time, whereas the Wegovy tablet, for example, must be taken on an empty stomach. Oral semaglutide requires taking it with a little water, on an empty stomach, followed by waiting at least half an hour before eating or drinking anything. Foundayo has none of these restrictions, and it also contains a different active ingredient: orforglipron is a small molecule, whereas semaglutide is a peptide. The table below compares the three variants side by side.

What are the side effects of Foundayo?

The side effects of Foundayo are similar to those of the entire GLP-1 class. These mainly involve gastrointestinal symptoms such as nausea, diarrhoea, vomiting and constipation, which are usually mild and temporary and occur primarily during the titration phase. You will recognise this pattern from the well-known side effects of GLP-1 medication, such as nausea. A recent review of new GLP-1 medication describes this side-effect profile as consistent across the class.

The Pharmacotherapeutic Compass describes the same category of gastrointestinal symptoms for the GLP-1 class, and, in rare cases, more serious problems such as pancreatitis or gallbladder symptoms. As Foundayo has only just been approved, long-term data are still limited. If you experience persistent or severe symptoms, always contact a doctor.

Is Foundayo already available in the Netherlands?

No, Foundayo is not yet available in the Netherlands. The medicine has been on the market in the United States since 1 April 2026, but it has not yet been approved in the Netherlands or the rest of the EU. The European assessment by the EMA is still ongoing, and European availability is not expected before 2027.

This also means that there is still no clarity regarding the exact indication, potential reimbursement or the precise launch date for the Dutch market. Anyone wishing to start treatment now can turn to the weight-loss medication that is currently available via a doctor. A doctor will assess whether such treatment is appropriate and safe.

Would you like to start taking weight-loss medication now? Goodweigh can help

Foundayo shows great promise, but is not yet available in the Netherlands. In the meantime, Goodweigh offers support with registered GLP-1 medication that is currently available. A Dutch doctor will assess, via an online intake, whether treatment is suitable for you and when you are eligible for GLP-1 medication. Would you like to know what that process involves? Find out how the online intake at Goodweigh works.

‍

‍